Wen-Ghih Tsang

Title: The Innovative Contributions of Wen-Ghih Tsang

Introduction

Wen-Ghih Tsang is a prominent inventor based in Sherman Oaks, California. He has made significant contributions to the field of biotechnology, particularly in the area of pancreatic cell research. With a total of seven patents to his name, Tsang's work has the potential to impact diabetes treatment and regenerative medicine.

Latest Patents

One of Tsang's latest patents is a method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture. This invention relates to the discovery that the proliferation and survival of pancreatic progenitor cells can be enhanced by contacting the cells with a caspase inhibitor sufficient to reduce apoptosis in the pancreatic endocrine cells, along with a growth factor in an amount sufficient to increase the level of activated Akt in these cells. Another notable patent is related to CD56 positive human adult pancreatic endocrine progenitor cells. This invention involves the discovery of a selective cell surface marker that allows for the selection of a unique subset of pancreatic stem cells that have a high propensity to differentiate into insulin-producing cells or into insulin-producing cell aggregates.

Career Highlights

Throughout his career, Tsang has worked with various companies, including Reneuron, Inc. and Amcyte, Inc. His innovative research has positioned him as a key figure in the advancement of pancreatic cell therapies.

Collaborations

Tsang has collaborated with notable colleagues, including Tianli Zheng and Yanping Wang, who have contributed to his research endeavors.

Conclusion

Wen-Ghih Tsang's innovative work in pancreatic cell research and his numerous patents highlight his significant contributions to biotechnology. His discoveries have the potential to pave the way for new treatments in diabetes and regenerative medicine.